Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX9O3R
|
||||
Drug Name |
(S)-2-amino-N-((S,E)-5-phenyl-1-(phenylsulfonyl)pent-1-en-3-yl)pentanamide
|
||||
Synonyms |
CHEMBL514348
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C22H28N2O3S
|
||||
Canonical SMILES |
CCC[C@H](N)C(=O)N[C@@H](CCc1ccccc1)\\C=C\\S(=O)(=O)c2ccccc2
|
||||
InChI |
InChI=1S/C22H28N2O3S/c1-2-9-21(23)22(25)24-19(15-14-18-10-5-3-6-11-18)16-17-28(26,27)20-12-7-4-8-13-20/h3-8,10-13,16-17,19,21H,2,9,14-15,23H2,1H3,(H,24,25)/b17-16+/t19-,21-/m0/s1
|
||||
InChIKey |
GLJZTHKUTGOBFU-LIIHMFIASA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin B | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
WikiPathways | RANKL/RANK Signaling Pathway | ||||
Osteoclast Signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.